Yahoo
Tokyo - Delayed Quote JPY

Santen Pharmaceutical Co., Ltd. (4536.T)

2,017.50 -3.00 (-0.15%)
At close: 3:30:00 PM GMT+9
View in AlphaSpace Currency in JPY All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
3/31/2024
3/31/2023
3/31/2022
Cash Flow from Operating Activities, Indirect
55,247,000 72,649,000 37,147,000 46,043,000
Cash Flow from Investing Activities
-7,663,000 -6,145,000 -26,777,000 -35,169,000
Cash Flow from Financing Activities
-55,157,000 -34,031,000 -37,220,000 5,557,000
Cash and Cash Equivalents, End of Period
77,851,000 94,582,000 57,903,000 83,014,000
Cash Flow, Supplemental
Free Cash Flow to Firm
44,970,159.32 50,174,616 19,261,197.40 9,944,942.14
Capital Expenditure, Calculated
12,123,000 10,687,000 24,588,000 35,841,000
Issuance of Capital Stock
0 0 0 0
Repurchase of Capital Stock
-37,883,000 -16,962,000 -26,007,000 -12,000
Free Cash Flow to Cash Flow from Operating Activities
0.78 0.82 0.43 0.20
3/31/2022 - 1/4/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: